vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Ribbon Communications Inc. (RBBN). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $162.6M, roughly 1.0× Ribbon Communications Inc.). Ribbon Communications Inc. runs the higher net margin — 54.8% vs -82.0%, a 136.7% gap on every dollar of revenue. On growth, Ribbon Communications Inc. posted the faster year-over-year revenue change (-10.3% vs -22.7%). Over the past eight quarters, Ribbon Communications Inc.'s revenue compounded faster (-8.1% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Ribbon Communications Inc. is a public company that makes software, IP and optical networking solutions for service providers, enterprises and critical infrastructure sectors. The company was formed in 2017, following the merger of Genband and Sonus Networks and is headquartered in Plano, Texas.

PTCT vs RBBN — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.0× larger
PTCT
$164.7M
$162.6M
RBBN
Growing faster (revenue YoY)
RBBN
RBBN
+12.4% gap
RBBN
-10.3%
-22.7%
PTCT
Higher net margin
RBBN
RBBN
136.7% more per $
RBBN
54.8%
-82.0%
PTCT
Faster 2-yr revenue CAGR
RBBN
RBBN
Annualised
RBBN
-8.1%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PTCT
PTCT
RBBN
RBBN
Revenue
$164.7M
$162.6M
Net Profit
$-135.0M
$89.1M
Gross Margin
42.9%
Operating Margin
-43.3%
37.6%
Net Margin
-82.0%
54.8%
Revenue YoY
-22.7%
-10.3%
Net Profit YoY
-104.8%
EPS (diluted)
$-1.63
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
RBBN
RBBN
Q1 26
$162.6M
Q4 25
$164.7M
$227.3M
Q3 25
$211.0M
$215.4M
Q2 25
$178.9M
$220.6M
Q1 25
$1.2B
$181.3M
Q4 24
$213.2M
$251.4M
Q3 24
$196.8M
$210.2M
Q2 24
$186.7M
$192.6M
Net Profit
PTCT
PTCT
RBBN
RBBN
Q1 26
$89.1M
Q4 25
$-135.0M
Q3 25
$15.9M
$-12.1M
Q2 25
$-64.8M
$-11.1M
Q1 25
$866.6M
$-26.2M
Q4 24
$-65.9M
Q3 24
$-106.7M
$-13.4M
Q2 24
$-99.2M
$-16.8M
Gross Margin
PTCT
PTCT
RBBN
RBBN
Q1 26
42.9%
Q4 25
53.3%
Q3 25
50.1%
Q2 25
49.6%
Q1 25
45.4%
Q4 24
55.7%
Q3 24
52.1%
Q2 24
50.8%
Operating Margin
PTCT
PTCT
RBBN
RBBN
Q1 26
37.6%
Q4 25
-43.3%
4.1%
Q3 25
1.4%
1.3%
Q2 25
-19.5%
1.9%
Q1 25
82.5%
-10.8%
Q4 24
-76.2%
13.2%
Q3 24
-27.7%
-0.4%
Q2 24
-21.5%
-1.0%
Net Margin
PTCT
PTCT
RBBN
RBBN
Q1 26
54.8%
Q4 25
-82.0%
Q3 25
7.5%
-5.6%
Q2 25
-36.3%
-5.0%
Q1 25
73.7%
-14.5%
Q4 24
-30.9%
Q3 24
-54.2%
-6.4%
Q2 24
-53.1%
-8.7%
EPS (diluted)
PTCT
PTCT
RBBN
RBBN
Q1 26
$0.50
Q4 25
$-1.63
$0.50
Q3 25
$0.20
$-0.07
Q2 25
$-0.83
$-0.06
Q1 25
$10.04
$-0.15
Q4 24
$-0.85
$0.05
Q3 24
$-1.39
$-0.08
Q2 24
$-1.29
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
RBBN
RBBN
Cash + ST InvestmentsLiquidity on hand
$1.9B
$67.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$419.1M
Total Assets
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
RBBN
RBBN
Q1 26
$67.6M
Q4 25
$1.9B
$96.4M
Q3 25
$1.7B
$74.8M
Q2 25
$2.0B
$60.5M
Q1 25
$2.0B
$71.2M
Q4 24
$1.1B
$87.8M
Q3 24
$1.0B
$37.2M
Q2 24
$1.1B
$64.6M
Total Debt
PTCT
PTCT
RBBN
RBBN
Q1 26
Q4 25
$342.1M
Q3 25
$344.3M
Q2 25
$346.5M
Q1 25
$347.4M
Q4 24
$348.3M
Q3 24
$349.1M
Q2 24
$350.0M
Stockholders' Equity
PTCT
PTCT
RBBN
RBBN
Q1 26
$419.1M
Q4 25
$-205.3M
$449.0M
Q3 25
$-155.8M
$360.1M
Q2 25
$-206.5M
$370.4M
Q1 25
$-185.8M
$381.8M
Q4 24
$-1.1B
$404.6M
Q3 24
$-1.1B
$395.5M
Q2 24
$-980.2M
$405.0M
Total Assets
PTCT
PTCT
RBBN
RBBN
Q1 26
Q4 25
$2.9B
$1.2B
Q3 25
$2.6B
$1.1B
Q2 25
$2.6B
$1.1B
Q1 25
$2.7B
$1.1B
Q4 24
$1.7B
$1.2B
Q3 24
$1.8B
$1.1B
Q2 24
$1.9B
$1.1B
Debt / Equity
PTCT
PTCT
RBBN
RBBN
Q1 26
Q4 25
0.76×
Q3 25
0.96×
Q2 25
0.94×
Q1 25
0.91×
Q4 24
0.86×
Q3 24
0.88×
Q2 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
RBBN
RBBN
Operating Cash FlowLast quarter
$-34.3M
Free Cash FlowOCF − Capex
$-36.6M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
RBBN
RBBN
Q1 26
Q4 25
$-34.3M
$29.2M
Q3 25
$-66.3M
$26.5M
Q2 25
$-58.3M
$-795.0K
Q1 25
$870.1M
$-3.5M
Q4 24
$-30.0M
$61.8M
Q3 24
$-77.0M
$-14.8M
Q2 24
$-71.5M
$-9.8M
Free Cash Flow
PTCT
PTCT
RBBN
RBBN
Q1 26
Q4 25
$-36.6M
$27.3M
Q3 25
$-69.7M
$21.0M
Q2 25
$-59.6M
$-6.5M
Q1 25
$868.4M
$-15.7M
Q4 24
$-33.8M
$53.8M
Q3 24
$-77.5M
$-23.7M
Q2 24
$-78.8M
$-12.9M
FCF Margin
PTCT
PTCT
RBBN
RBBN
Q1 26
Q4 25
-22.3%
12.0%
Q3 25
-33.1%
9.7%
Q2 25
-33.3%
-2.9%
Q1 25
73.8%
-8.7%
Q4 24
-15.8%
21.4%
Q3 24
-39.4%
-11.3%
Q2 24
-42.2%
-6.7%
Capex Intensity
PTCT
PTCT
RBBN
RBBN
Q1 26
Q4 25
1.4%
0.9%
Q3 25
1.6%
2.6%
Q2 25
0.7%
2.6%
Q1 25
0.1%
6.7%
Q4 24
1.8%
3.2%
Q3 24
0.3%
4.2%
Q2 24
4.0%
1.6%
Cash Conversion
PTCT
PTCT
RBBN
RBBN
Q1 26
Q4 25
Q3 25
-4.17×
Q2 25
Q1 25
1.00×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

RBBN
RBBN

Service$94.5M58%
Product$68.1M42%

Related Comparisons